Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Professional Survey Report Forecast 2017-2021
This report studies Non-alcoholic Fatty Liver Disease (NAFLD) Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2017, and forecast to 2021.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Conatus Pharmaceuticals
Daewoong Pharmaceutical
Galmed International
Kyorin Pharmaceutical
Metabolic Solutions Development
Novartis AG
Phenex Pharmaceuticals
Raptor Pharmaceuticals
TCM Biotech International
By types, the market can be split into
Type 1
Type 2
Type 3
By Application, the market can be split into
Application 1
Application 2
Application 3
By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Conatus Pharmaceuticals
Daewoong Pharmaceutical
Galmed International
Kyorin Pharmaceutical
Metabolic Solutions Development
Novartis AG
Phenex Pharmaceuticals
Raptor Pharmaceuticals
TCM Biotech International
By types, the market can be split into
Type 1
Type 2
Type 3
By Application, the market can be split into
Application 1
Application 2
Application 3
By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India
Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Professional Survey Report 2017
1 INDUSTRY OVERVIEW OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG
1.1 Definition and Specifications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.1.1 Definition of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.1.2 Specifications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2 Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2.1 Type
1.2.2 Type
1.2.3 Type
1.3 Applications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.3.2 Application
1.3.3 Application
1.3.4 Application
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 MANUFACTURING COST STRUCTURE ANALYSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
2.3 Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
2.4 Industry Chain Structure of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG
3.1 Capacity and Commercial Production Date of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2016
4 GLOBAL NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG OVERALL MARKET OVERVIEW
4.1 2012-2017 Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity and Growth Rate Analysis
4.2.2 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Analysis
4.3.2 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price
4.4.2 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis (Company Segment)
5 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG REGIONAL MARKET ANALYSIS
5.1 North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis
5.1.1 North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
5.1.2 North America 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis
5.1.4 North America 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis
5.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis
5.2.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
5.2.2 China 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis
5.2.4 China 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis
5.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis
5.3.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
5.3.2 Europe 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis
5.3.4 Europe 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis
5.4 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis
5.4.1 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
5.4.2 Southeast Asia 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis
5.4.4 Southeast Asia 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis
5.5 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis
5.5.1 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
5.5.2 Japan 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis
5.5.4 Japan 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis
5.6 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis
5.6.1 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
5.6.2 India 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis
5.6.4 India 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis
6 GLOBAL 2012-2017 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG SEGMENT MARKET ANALYSIS (BY TYPE)
6.1 Global 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type
6.2 Different Types of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Interview Price Analysis
6.3 Different Types of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Driving Factors Analysis
6.3.1 General keyboard membrane of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis
6.3.2 Transparent keyboard membrane of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis
6.3.3 Simulation keyboard membrane of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis
6.3.4 Colorful keyboard membrane of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis
6.3.5 Other of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis
7 GLOBAL 2012-2017 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG SEGMENT MARKET ANALYSIS (BY APPLICATION)
7.1 Global 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption by Application
7.2 Different Application of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Interview Price Analysis
7.3 Different Application of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Driving Factors Analysis
7.3.1 Office Use of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis
7.3.2 Personal Use of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis
8 MAJOR MANUFACTURERS ANALYSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG
8.1 Conatus Pharmaceuticals
8.1.1 Company Basic Information, Manufacturing Base and Competitors
8.1.2 Product Picture and Specifications
8.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
8.1.4 Business Overview
8.2 Daewoong Pharmaceutical
8.2.1 Company Basic Information, Manufacturing Base and Competitors
8.2.2 Product Picture and Specifications
8.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
8.2.4 Business Overview
8.3 Galmed International
8.3.1 Company Basic Information, Manufacturing Base and Competitors
8.3.2 Product Picture and Specifications
8.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
8.3.4 Business Overview
8.4 Kyorin Pharmaceutical
8.4.1 Company Basic Information, Manufacturing Base and Competitors
8.4.2 Product Picture and Specifications
8.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
8.4.4 Business Overview
8.5 Metabolic Solutions Development
8.5.1 Company Basic Information, Manufacturing Base and Competitors
8.5.2 Product Picture and Specifications
8.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
8.5.4 Business Overview
8.6 Novartis AG
8.6.1 Company Basic Information, Manufacturing Base and Competitors
8.6.2 Product Picture and Specifications
8.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
8.6.4 Business Overview
8.7 Phenex Pharmaceuticals
8.7.1 Company Basic Information, Manufacturing Base and Competitors
8.7.2 Product Picture and Specifications
8.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
8.7.4 Business Overview
8.8 Raptor Pharmaceuticals
8.8.1 Company Basic Information, Manufacturing Base and Competitors
8.8.2 Product Picture and Specifications
8.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
8.8.4 Business Overview
8.9 TCM Biotech International
8.9.1 Company Basic Information, Manufacturing Base and Competitors
8.9.2 Product Picture and Specifications
8.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
8.9.4 Business Overview
9 DEVELOPMENT TREND OF ANALYSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MARKET
9.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Trend Analysis
9.1.1 Global 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Forecast
9.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Regional Market Trend
9.2.1 North America 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast
9.2.2 China 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast
9.2.3 Europe 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast
9.2.4 Southeast Asia 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast
9.2.5 Japan 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast
9.2.6 India 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast
9.3 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Trend (Product Type)
9.4 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Trend (Application)
10 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MARKETING TYPE ANALYSIS
10.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Regional Marketing Type Analysis
10.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Regions
10.4 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Supply Chain Analysis
11 CONSUMERS ANALYSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 APPENDIX
1 INDUSTRY OVERVIEW OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG
1.1 Definition and Specifications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.1.1 Definition of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.1.2 Specifications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2 Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2.1 Type
1.2.2 Type
1.2.3 Type
1.3 Applications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.3.2 Application
1.3.3 Application
1.3.4 Application
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 MANUFACTURING COST STRUCTURE ANALYSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
2.3 Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
2.4 Industry Chain Structure of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG
3.1 Capacity and Commercial Production Date of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2016
4 GLOBAL NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG OVERALL MARKET OVERVIEW
4.1 2012-2017 Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity and Growth Rate Analysis
4.2.2 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Analysis
4.3.2 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price
4.4.2 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis (Company Segment)
5 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG REGIONAL MARKET ANALYSIS
5.1 North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis
5.1.1 North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
5.1.2 North America 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis
5.1.4 North America 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis
5.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis
5.2.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
5.2.2 China 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis
5.2.4 China 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis
5.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis
5.3.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
5.3.2 Europe 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis
5.3.4 Europe 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis
5.4 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis
5.4.1 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
5.4.2 Southeast Asia 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis
5.4.4 Southeast Asia 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis
5.5 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis
5.5.1 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
5.5.2 Japan 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis
5.5.4 Japan 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis
5.6 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis
5.6.1 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
5.6.2 India 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis
5.6.4 India 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis
6 GLOBAL 2012-2017 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG SEGMENT MARKET ANALYSIS (BY TYPE)
6.1 Global 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type
6.2 Different Types of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Interview Price Analysis
6.3 Different Types of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Driving Factors Analysis
6.3.1 General keyboard membrane of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis
6.3.2 Transparent keyboard membrane of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis
6.3.3 Simulation keyboard membrane of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis
6.3.4 Colorful keyboard membrane of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis
6.3.5 Other of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis
7 GLOBAL 2012-2017 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG SEGMENT MARKET ANALYSIS (BY APPLICATION)
7.1 Global 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption by Application
7.2 Different Application of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Interview Price Analysis
7.3 Different Application of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Driving Factors Analysis
7.3.1 Office Use of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis
7.3.2 Personal Use of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis
8 MAJOR MANUFACTURERS ANALYSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG
8.1 Conatus Pharmaceuticals
8.1.1 Company Basic Information, Manufacturing Base and Competitors
8.1.2 Product Picture and Specifications
8.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
8.1.4 Business Overview
8.2 Daewoong Pharmaceutical
8.2.1 Company Basic Information, Manufacturing Base and Competitors
8.2.2 Product Picture and Specifications
8.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
8.2.4 Business Overview
8.3 Galmed International
8.3.1 Company Basic Information, Manufacturing Base and Competitors
8.3.2 Product Picture and Specifications
8.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
8.3.4 Business Overview
8.4 Kyorin Pharmaceutical
8.4.1 Company Basic Information, Manufacturing Base and Competitors
8.4.2 Product Picture and Specifications
8.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
8.4.4 Business Overview
8.5 Metabolic Solutions Development
8.5.1 Company Basic Information, Manufacturing Base and Competitors
8.5.2 Product Picture and Specifications
8.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
8.5.4 Business Overview
8.6 Novartis AG
8.6.1 Company Basic Information, Manufacturing Base and Competitors
8.6.2 Product Picture and Specifications
8.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
8.6.4 Business Overview
8.7 Phenex Pharmaceuticals
8.7.1 Company Basic Information, Manufacturing Base and Competitors
8.7.2 Product Picture and Specifications
8.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
8.7.4 Business Overview
8.8 Raptor Pharmaceuticals
8.8.1 Company Basic Information, Manufacturing Base and Competitors
8.8.2 Product Picture and Specifications
8.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
8.8.4 Business Overview
8.9 TCM Biotech International
8.9.1 Company Basic Information, Manufacturing Base and Competitors
8.9.2 Product Picture and Specifications
8.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
8.9.4 Business Overview
9 DEVELOPMENT TREND OF ANALYSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MARKET
9.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Trend Analysis
9.1.1 Global 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Forecast
9.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Regional Market Trend
9.2.1 North America 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast
9.2.2 China 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast
9.2.3 Europe 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast
9.2.4 Southeast Asia 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast
9.2.5 Japan 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast
9.2.6 India 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast
9.3 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Trend (Product Type)
9.4 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Trend (Application)
10 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MARKETING TYPE ANALYSIS
10.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Regional Marketing Type Analysis
10.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Regions
10.4 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Supply Chain Analysis
11 CONSUMERS ANALYSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 APPENDIX
LIST OF TABLES AND FIGURES
Figure Picture of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Product Specifications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Global Production Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type in 2016
Table Applications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Global Consumption Volume Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Application in 2016
Figure Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Regions
Figure North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)
Figure Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)
Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)
Figure India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)
Table Non-alcoholic Fatty Liver Disease (NAFLD) Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug in 2016
Figure Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Industry Chain Structure of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Capacity and Commercial Production Date of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2012-2017
Figure Global 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (Volume) and Growth Rate
Figure Global 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (Value) and Growth Rate
Table 2012-2017 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity and Growth Rate
Table 2016 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity List (Company Segment)
Table 2012-2017 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate
Table 2016 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales List (Company Segment)
Table 2012-2017 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price
Table 2016 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2012-2017
Figure North America 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price
Figure North America 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2012-2017
Figure China 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price
Figure China 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2012-2017
Figure Europe 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price
Figure Europe 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2012-2017
Figure Southeast Asia 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price
Figure Southeast Asia 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2012-2017
Figure Japan 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price
Figure Japan 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2012-2017
Figure India 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price
Figure India 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share
Table Global 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type
Table Different Types Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Interview Price
Table Global 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application
Table Different Application Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Interview Price
Table Conatus Pharmaceuticals Basic Information List
Table Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Daewoong Pharmaceutical Basic Information List
Table Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Galmed International Basic Information List
Table Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Kyorin Pharmaceutical Basic Information List
Table Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Metabolic Solutions Development Basic Information List
Table Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Phenex Pharmaceuticals Basic Information List
Table Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Raptor Pharmaceuticals Basic Information List
Table Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table TCM Biotech International Basic Information List
Table TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Figure Global 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (Volume) and Growth Rate Forecast
Figure Global 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (Value) and Growth Rate Forecast
Figure Global 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Forecast
Figure North America 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast
Figure China 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast
Figure Europe 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast
Figure Japan 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast
Figure India 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast
Table Global Sales Volume of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Types 2017-2021
Table Global Consumption Volume of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Applications 2017-2021
Table Traders or Distributors with Contact Information of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Regions
COMPANIES MENTIONED
Conatus Pharmaceuticals, Daewoong Pharmaceutical, Galmed International, Kyorin Pharmaceutical, Metabolic Solutions Development, Novartis AG, Phenex Pharmaceuticals, Raptor Pharmaceuticals, TCM Biotech International, Tobira Therapeutics, Verva Pharmaceuticals, Zafgen
Figure Picture of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Product Specifications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Global Production Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type in 2016
Table Applications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Global Consumption Volume Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Application in 2016
Figure Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Regions
Figure North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)
Figure Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)
Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)
Figure India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)
Table Non-alcoholic Fatty Liver Disease (NAFLD) Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug in 2016
Figure Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Industry Chain Structure of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Capacity and Commercial Production Date of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2012-2017
Figure Global 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (Volume) and Growth Rate
Figure Global 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (Value) and Growth Rate
Table 2012-2017 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity and Growth Rate
Table 2016 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity List (Company Segment)
Table 2012-2017 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate
Table 2016 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales List (Company Segment)
Table 2012-2017 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price
Table 2016 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2012-2017
Figure North America 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price
Figure North America 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2012-2017
Figure China 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price
Figure China 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2012-2017
Figure Europe 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price
Figure Europe 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2012-2017
Figure Southeast Asia 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price
Figure Southeast Asia 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2012-2017
Figure Japan 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price
Figure Japan 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2012-2017
Figure India 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price
Figure India 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share
Table Global 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type
Table Different Types Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Interview Price
Table Global 2012-2017 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application
Table Different Application Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Interview Price
Table Conatus Pharmaceuticals Basic Information List
Table Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Daewoong Pharmaceutical Basic Information List
Table Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Galmed International Basic Information List
Table Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Kyorin Pharmaceutical Basic Information List
Table Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Metabolic Solutions Development Basic Information List
Table Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Phenex Pharmaceuticals Basic Information List
Table Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Raptor Pharmaceuticals Basic Information List
Table Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table TCM Biotech International Basic Information List
Table TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Figure Global 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (Volume) and Growth Rate Forecast
Figure Global 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (Value) and Growth Rate Forecast
Figure Global 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Forecast
Figure North America 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast
Figure China 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast
Figure Europe 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast
Figure Japan 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast
Figure India 2017-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast
Table Global Sales Volume of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Types 2017-2021
Table Global Consumption Volume of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Applications 2017-2021
Table Traders or Distributors with Contact Information of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Regions
COMPANIES MENTIONED
Conatus Pharmaceuticals, Daewoong Pharmaceutical, Galmed International, Kyorin Pharmaceutical, Metabolic Solutions Development, Novartis AG, Phenex Pharmaceuticals, Raptor Pharmaceuticals, TCM Biotech International, Tobira Therapeutics, Verva Pharmaceuticals, Zafgen
